These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 29013912)

  • 21. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma macrophage colony-stimulating factor and P-selectin levels in malaria-associated thrombocytopenia.
    Lee SH; Looareesuwan S; Chan J; Wilairatana P; Vanijanonta S; Chong SM; Chong BH
    Thromb Haemost; 1997 Feb; 77(2):289-93. PubMed ID: 9157583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
    Laufer MK; Plowe CV
    Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
    Karunajeewa HA; Reeder J; Lorry K; Dabod E; Hamzah J; Page-Sharp M; Chiswell GM; Ilett KF; Davis TM
    Antimicrob Agents Chemother; 2006 Mar; 50(3):968-74. PubMed ID: 16495259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of new drugs for chemoprophylaxis of malaria.
    Milhous WK
    Med Trop (Mars); 2001; 61(1):48-50. PubMed ID: 11584654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomics-based drug design targets the AT-rich malaria parasite: implications for antiparasite chemotherapy.
    Yanow SK; Purcell LA; Lee M; Spithill TW
    Pharmacogenomics; 2007 Sep; 8(9):1267-72. PubMed ID: 17924840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.
    Plowe CV; Roper C; Barnwell JW; Happi CT; Joshi HH; Mbacham W; Meshnick SR; Mugittu K; Naidoo I; Price RN; Shafer RW; Sibley CH; Sutherland CJ; Zimmerman PA; Rosenthal PJ
    Malar J; 2007 Sep; 6():121. PubMed ID: 17822535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Malaria situation in the People's Republic Of China in 2009].
    Zhou SS; Wang Y; Xia ZG
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Feb; 29(1):1-3. PubMed ID: 21823314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malaria situation in the People's Republic Of China in 2007.
    Zhou SS; Wang Y; Fang W; Tang LH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):401-3. PubMed ID: 19288908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malaria situation in the People's Republic of China in 2010].
    Zhou SS; Wang Y; Li Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Dec; 29(6):401-3. PubMed ID: 24822335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug repositioning in the treatment of malaria and TB.
    Nzila A; Ma Z; Chibale K
    Future Med Chem; 2011 Sep; 3(11):1413-26. PubMed ID: 21879845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clearance of circulating Epstein-Barr virus DNA in children with acute malaria after antimalaria treatment.
    Donati D; Espmark E; Kironde F; Mbidde EK; Kamya M; Lundkvist A; Wahlgren M; Bejarano MT; Falk KI
    J Infect Dis; 2006 Apr; 193(7):971-7. PubMed ID: 16518759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaria drug resistant: current situation with reference to Saudi Arabia (review).
    Al-Harthi SA
    J Egypt Soc Parasitol; 2011 Dec; 41(3):553-64. PubMed ID: 22435149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
    Patel SN; Kain KC
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidemiology of malaria in the Papua New Guinea highlands: 4. Enga Province.
    Mueller I; Ousari M; Yala S; Ivivi R; Sie A; Reeder JC
    P N G Med J; 2006; 49(3-4):115-25. PubMed ID: 18389969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current drugs for the treatment of tropical malaria].
    Fernex M; Jaquet C; Mittelholzer ML; Reber R; Stürchler D
    Schweiz Rundsch Med Prax; 1991 Jan; 80(4):67-71. PubMed ID: 1998081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in nanomedicines for malaria treatment.
    Aditya NP; Vathsala PG; Vieira V; Murthy RS; Souto EB
    Adv Colloid Interface Sci; 2013 Dec; 201-202():1-17. PubMed ID: 24192063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Modern treatment of malaria].
    Popov AF; Nikiforov ND; Sergiev VP; Sanin BI
    Klin Med (Mosk); 2003; 81(7):15-9. PubMed ID: 12934303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.